M/S Jagsonpal Pharmaceuticals Ltd v. Drugs Controller General Of India And ANR

$~36 *

IN THE HIGH COURT OF DELHI AT NEW DELHI

+ W.P.(C) 5725/2016 & CM No.23638/2016 M/S JAGSONPAL PHARMACEUTICALS LTD ..... Petitioner Through Mr. Vivek Singh Bishnoi with Mr. Mohit Kumar, Advocates.

versus DRUGS CONTROLLER GENERAL OF INDIA AND ANR ..... Respondents Through Mr. Ripu Daman Bhardwaj, CGSC with Mr. T.P. Singh, Advocate for UOI.

CORAM:

HON'BLE MR. JUSTICE SANJEEV SACHDEVA

O R D E R

% 21.12.2016 This petition impugns Notification dated 10.03.2016 of the Government of India in purported exercise of powers under Section 26A of the Drugs & Cosmetics Act, 1940 in respect of fixed dose combination drugs. Learned counsel for the parties on the first date had contended that this petition raises identical issues, as arising in WP(C) 2212/2016. A Coordinate Bench of this Court, by judgment dated 01.12.2016 in WP(C) 2212/2016, has quashed all the 344 Notifications dated 10.03.2016. The Notification in issue is also part of the 344 Notifications. In view of the fact that the issue, arising in the present petition, is identical to the issue arising in WP(C) 2212/2016 and other connected matters and the Notification in issue has been quashed, accordingly, the writ petition is disposed of in terms of judgment dated 01.12.2016 in WP(C) 2212/2016 titled Pfizer Ltd. & Anr. vs. Union of India & Anr.

SANJEEV SACHDEVA, J DECEMBER 21, 2016/st